The need for sustaining mpox vaccination in Africa.
Where this comes from
- Record sourced from PubMed, PMID 42236725.
- Also identified by DOI 10.1038/s41467-026-74075-z and PMC identifier 13269932.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sustaining and transitioning mpox vaccination requires establishing and resourcing a global mpox vaccine stockpile under the Inter-Agency Coordinating Group (ICG), supported by sustainable financing, transparent allocation criteria, diversified manufacturing (including local production in Africa), and robust logistics, surveillance, and operational systems. Moreover, it requires strengthened collaboration among global, regional, and community actors; continuous data generation and research to inform policy, including genomic and vaccine effectiveness studies; and accelerated R&D with fast-tracked local manufacturing to enhance supply resilience and long-term epidemic preparedness.